# R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)

> **NCT07646028** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Rise Therapeutics LLC** · enrollment: 20 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** R-3750

## Key facts

- **NCT ID:** NCT07646028
- **Lead sponsor:** Rise Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-10-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646028, "R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*